1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis
Agnieszka Błażejczyk(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy), Joanna Wietrzyk(Ludwik Hirszfeld Institute of Immunology and Experimental Therapy)
Cited by 38
Related Papers
Antiangiogenic cancer treatment: The great discovery and greater complexity (Review)
|International Journal of Oncology|2016|148